Atlas Trials

Phase 2

89,854 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 2

RecordFirmDate
Efficacy of Nitazoxanide in the Treatment of Chronic Hepatitis C Virus (HCV) (NCT01276756)Cairo University2010-12-01
Pazopanib In Stage IIIB/IV NSCLC Lung Cancer After Progression on First Line Therapy Containing Bevacizumab (NCT01262820)UNC Lineberger Comprehensive Cancer Center2010-12-01
Human Heterologous Liver Cells for Infusion in Children With Urea Cycle Disorders (NCT01195753)Cytonet GmbH & Co. KG2010-12-01
Prolonged Exposure for Post Traumatic Stress Disorder (PTSD) With/Without Yohimbine (NCT01031979)VA Office of Research and Development2010-12-01
Evaluation of Neuroprotective Effect of Minocycline (NCT01297816)Shahid Beheshti University of Medical Sciences2010-12-01
A Study of Multiple Oral Doses of JNJ-41443532 in Patients With Type 2 Diabetes Mellitus (NCT01230749)Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2010-12-01
Pharmacokinetics of 9-cis-retinoic Acid (Alitretinoin, Toctino®) in Patients With Hepatic Disease (NCT01261923)University Hospital, Gentofte, Copenhagen2010-12-01
Safety and Efficacy of Bepotastine Besilate Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (NCT01277341)Bausch & Lomb Incorporated2010-12-01
SB705498 Proof of Concept Chamber Challenge in Subjects With Non Allergic Rhinitis (NCT01424514)GlaxoSmithKline2010-12-01
Lenalidomide in HTLV-1 Adult T-Cell Leukemia (NCT01274533)Columbia University2010-12-01
Naloxone for the Treatment of Opioid-Induced Pruritus (NCT01071057)University of British Columbia2010-12-01
A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542) (NCT01451151)Aderans Research Institute2010-12-01
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion (NCT01222117)Grifols Therapeutics LLC2010-12-01
Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy (NCT01159327)National Cancer Center, Korea2010-12-01
Ginseng in Treatment of Fatigue in Multiple Sclerosis (NCT01712373)Isfahan University of Medical Sciences2010-12-01
Efficacy and Safety of Bevacizumab/Temsirolimus Combination to Treat Advanced Renal Cell Carcinoma (NCT01264341)Hellenic Cooperative Oncology Group2010-12-01
Pilot Study for Locally Advanced Head and Neck Cancer (NCT01262859)University of Pittsburgh2010-12-01
Human Adipose Derived Mesenchymal Stem Cells for Critical Limb Ischemia (CLI) in Diabetic Patients (NCT01257776)Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud2010-12-01
Study of Cimzia for the Treatment of Ulcerative Colitis (NCT01090154)University of Washington2010-12-01
Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer (NCT01123473)European Organisation for Research and Treatment of Cancer - EORTC2010-12-01
Cognitive Remediation and Work Therapy in the Initial Phase of Substance Abuse Treatment (NCT01410110)Yale University2010-12-01
Bosentan for Severe Mitral Valve Dysfunction (NCT01270750)General Hospital of Chalkida2010-12-01
Ondansetron, Alcohol Use, and Alcohol-Related Symptoms In HIV+ Persons (NCT01254877)Johns Hopkins University2010-12-01
Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC) (NCT01424709)Tongji University2010-12-01
Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer (NCT01308840)University of Rochester2010-12-01
Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma (NCT01122901)National Cancer Institute (NCI)2010-12-01
Immunogenicity and Safety of Different rMenB Plus MenACWY Formulations in Adolescents (NCT01210885)Novartis Vaccines2010-12-01
Lenalidomide and Rituximab in Subjects With Previously Untreated Indolent Non-Hodgkin's Lymphoma (NCT01316523)University of California, Davis2010-12-01
FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only (NCT01226719)SCRI Development Innovations, LLC2010-12-01
Etanercept for the Treatment of Chronic Urticaria (NCT01030120)University of Utah2010-12-01
Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer (NCT01222572)Dana-Farber Cancer Institute2010-12-01
Phase 1 and 2 Study of PX-866 and Cetuximab (NCT01252628)Cascadian Therapeutics Inc.2010-12-01
Trial on Treatment of Patients With Primary Hyperoxaluria Type I With Pyridoxal-phosphate (NCT01281878)University of Cologne2010-12-01
Pilot Study: Lactoferrin for Prevention of Neonatal Sepsis (NCT01264536)Universidad Peruana Cayetano Heredia2010-12-01
Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL) (NCT01295593)Cliniques universitaires Saint-Luc- Université Catholique de Louvain2010-12-01
Open Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycythemia Vera (NCT01243073)Geron Corporation2010-12-01
Evaluation of a New HIV Prevention Intervention for Black Bisexually-active Men (NCT01347164)Public Health Management Corporation2010-12-01
IGF-1 Inhibitor Pasireotide Lar in Combination With the m-TOR Inhibitor Everolimus (NCT01234974)Milton S. Hershey Medical Center2010-12-01
Cell Therapy in Patients With Chronic Ischemic Heart Disease Undergoing Cardiac Surgery (NCT01267331)Chinese PLA General Hospital2010-12-01
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma (NCT01269437)NovaMed Pharmaceuticals Inc.2010-12-01
Ofatumumab for Initial Systemic Treatment of Indolent B-cell Lymphoma (NCT01239394)Massachusetts General Hospital2010-12-01
Safety and Efficacy Study Adding GSK2190915 to Mid-dose Inhaled Corticosteroid/Long Acting Beta Agonist Combination Treatment for Asthma (NCT01248975)GlaxoSmithKline2010-12-01
Study of Cetuximab in Combination With mFOLFOX-6 (Oxaliplatin, Leucovorin, 5-FU) to Treat Colorectal Liver Metastatic Cancer Patients (NCT01322178)Fudan University2010-12-01
Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Colorectal Cancer (NCT01305980)SBPharmaceutical IND, Co., LTD2010-12-01
RO4929097 After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma (NCT01251172)National Cancer Institute (NCI)2010-12-01
Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma (NCT01258998)National Cancer Institute (NCI)2010-12-01
Lapatinib or Trastuzumab Given Prior to Surgery With Chemotherapy in Patients With Early Breast Cancer (NCT01205217)GlaxoSmithKline2010-12-01
Nasopharyngeal Carcinoma (NPC) Axitinib (NCT01249547)Chinese University of Hong Kong2010-12-01
Efficacy & Safety in Moderately Active Refractory Ulcerative Colitis Patients (NCT01375179)Novartis Pharmaceuticals2010-12-01
Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer (NCT01270438)National Cancer Institute (NCI)2010-12-01
First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma (NCT01215136)Matthew Galsky2010-12-01
Green Tea Extract: a Non-Surgical Alternative for Treatment of Uterine Fibroids (NCT01311869)Meharry Medical College2010-12-01
Assessing BAY86-9766 Plus Sorafenib for the Treatment of Liver Cancer. (NCT01204177)Bayer2010-12-01
Dose-finding of Multiple Dose of BT061 in Patients With Active Rheumatoid Arthritis Incompletely Controlled on Stable Methotrexate (MTX) (NCT01481493)Biotest2010-12-01
Amgen 386 for Recurrent Glioblastoma (NCT01290263)Dana-Farber Cancer Institute2010-12-01
Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT) (NCT01261429)Centre Leon Berard2010-12-01
Revlimid Dose 25 mg in Association With (R-CHOP) in the Treatment Follicular Lymphoma (NCT01393756)The Lymphoma Academic Research Organisation2010-12-01
Improving the Efficacy of Anti-Nicotine Immunotherapy (NCT01280968)Alexey Mukhin2010-12-01
A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Vehicle in Subjects With Blepharitis (P08636) (NCT01269658)Merck Sharp & Dohme LLC2010-12-01
Evaluation of Magnetic Fields to Treat Fibromyalgia (NCT01262131)pico-tesla Magnetic Therapies, LLC2010-12-01
Gemcitabine/Cisplatin/S-1(GCS) Combination Therapy for Patients With Advanced Biliary Tract Cancer (NCT01284413)Kansai Hepatobiliary Oncology Group2010-12-01
Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients (NCT01882985)University of California, Irvine2010-12-01
Comparative Study of Coadministered Ceftaroline Fosamil and NXL104 vs. Intravenous Doripenem in Adult Subjects With Complicated Urinary Tract Infections (NCT01281462)Forest Laboratories2010-12-01
Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg (NCT01257425)Ipsen2010-12-01
In Vivo Assessment of Silver Biomaterial Nano-Toxicity (NCT01243320)University of Utah2010-12-01
Safety and Tolerability Study for Age-Related Macular Degeneration (NCT01485588)Iconic Therapeutics, Inc.2010-12-01
Minimization of IntraLipid Versus Omegaven (NCT01247012)Children's & Women's Health Centre of British Columbia2010-12-01
Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women (NCT01266213)Samsung Medical Center2010-12-01
Phase l/II Study of Ruxolitinib for Acute Leukemia (NCT01251965)M.D. Anderson Cancer Center2010-12-01
Impact of Cancer on Memory Functioning: Understanding Disorders Using Approaches in Neuropsychology and Neuroimaging (NCT01332916)Centre Francois Baclesse2010-12-01
A Clinical Trial to Evaluate the Safety and Efficacy of Ciprofloxacin in the Treatment of Plague in Humans (NCT01243437)Centers for Disease Control and Prevention2010-12-01
Stress Reduction in Middle Eastern Refugees (NCT01288690)Wayne State University2010-12-01
Vitamin D Supplementation in Breastfeeding Women (NCT01240265)Mayo Clinic2010-12-01
Safety of Heparin in Patients With Septic Shock (NCT01234285)University of Colorado, Denver2010-12-01
A Study of RO5185426 in Patients With Metastatic Melanoma (NCT01248936)Hoffmann-La Roche2010-12-01
Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy (NCT01235572)Fred Hutchinson Cancer Center2010-12-01
Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer (NCT01126645)University of Magdeburg2010-12-01
Post-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) Transplant (NCT01244906)Northside Hospital, Inc.2010-12-01
Study in Genotype 2 or 3 Patients With Chronic Hepatitis Virus Infection (NCT01257204)Bristol-Myers Squibb2010-12-01
Efficacy and Safety of Two Treatment Regimens of Topical MOB015 in Adults With Distal Subungual Onychomycosis (NCT01246518)Moberg Pharma AB2010-12-01
Safety and Efficacy Study of Antioxidants for the Treatment of the Fragile X Syndrome (NCT01329770)Yolanda de Diego Otero2010-12-01
A Study of MEMP1972A in the Prevention of Allergen-Induced Airway Obstruction in Patients With Mild Asthma (SOLARIO) (NCT01196039)Genentech, Inc.2010-12-01
A Multi-center, Open-label, Randomized, Parallel Group Study to Evaluate Pharmacokinetic Profile, Effects on the Mechanisms of Contraceptive Efficacy and Safety of Two Progestin-only Patches Containing Different Doses of Levonorgestrel (LNG) (NCT01166412)Premier Research2010-12-01
Intravenous Magnesium for Sickle Cell Vasoocclusive Crisis (NCT01197417)Medical College of Wisconsin2010-12-01
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy (NCT01200394)Pfizer2010-12-01
Mesenchymal Stem Cell Transplantation in MS (NCT01228266)Albert Saiz2010-12-01
Safety and Efficacy of QAX576 in Patients With Idiopathic Pulmonary Fibrosis (IPF) (NCT01266135)Novartis Pharmaceuticals2010-12-01
Early Embryo Cleavage And Multiple Pregnancies After ICSI (NCT02265055)Al-Azhar University2010-12-01
A Study Of Tasocitinib In Dry Eye Subjects (NCT01226680)Pfizer2010-12-01
Proof of Activity Study of UR-63325 in Allergic Rhinitis Induced by Nasal Challenge (NCT01260753)Palau Pharma S.L.U.2010-12-01
Gene Therapy for X-linked Severe Combined Immunodeficiency (NCT01410019)Assistance Publique - Hôpitaux de Paris2010-12-01
Efficacy and Safety of Panitumumab Combined With Docetaxel and Cisplatin as a First-line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (NCT01379807)Grupo Gallego de Investigaciones Oncologicas2010-12-01
Prevention of Varicella Zoster Virus (VZV)-Reactivation in HIV-positive Individuals Enrolled in a Prospective Immunogenicity and Safety Trial of VZV Vaccine: PROVE-IT-Study (NCT01213810)University of Zurich2010-12-01
A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo (NCT01299610)GlaxoSmithKline2010-12-01
Intracoronary Infusion of Bone Marrow Mononuclear Cells in Patients With Previous Myocardial Infarction. (NCT01454323)Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud2010-12-01
A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2) (NCT01258803)Organon and Co2010-12-01
Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067) (NCT01045798)Merck Sharp & Dohme LLC2010-12-01
Safety and Efficacy Study of Omalizumab to Treat Allergic Asthma (NCT01976208)Shanghai Zhangjiang Biotechnology Limited Company2010-12-01
Safety and Efficacy of AZD4547 in Combination With Fulvestrant vs. Fulvestrant Alone in ER+ Breast Cancer Patients (NCT01202591)AstraZeneca2010-12-01
A Safety and Efficacy Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies (NCT01263899)S*BIO2010-12-01
← Previous Next →

Track Phase 2 automatically

Every clearance here is in the API, with alerts when new ones post.